Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 4.0 | 4.0 |
Min SIP Amount | ₹500 | ₹500 |
Expense Ratio | 1.77 | 1.72 |
NAV | ₹2788.95 | ₹184.92 |
Fund Started | 30 Oct 1993 | 15 Feb 2007 |
Fund Size | ₹12770.14 Cr | ₹9319.87 Cr |
Exit Load | Exit load of 1% if redeemed within 1 year | Exit load for units in excess of 10% of the investment, 1% will be charged for redemption within 1 year. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 4.76% | 13.47% |
3 Year | 22.10% | 27.11% |
5 Year | 21.14% | 25.72% |
1 Year
3 Year
5 Year
Equity | 96.55% | 99.43% |
Cash | 3.25% | 0.57% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
The Federal Bank Ltd. | 3.02% |
Cummins India Ltd. | 2.44% |
Mphasis Ltd. | 2.28% |
Prestige Estates Projects Ltd. | 2.23% |
Mahindra & Mahindra Financial Services Ltd. | 2.13% |
APL Apollo Tubes Ltd. | 2.10% |
IDFC First Bank Ltd. | 1.85% |
PB Fintech Ltd. | 1.82% |
Biocon Ltd. | 1.71% |
Coforge Ltd. | 1.69% |
Name | Assets |
|---|---|
AU Small Finance Bank Ltd. | 5.59% |
Swiggy Ltd. | 5.23% |
The Federal Bank Ltd. | 5.07% |
L&T Finance Ltd. | 4.89% |
Prestige Estates Projects Ltd. | 4.59% |
BSE Ltd. | 4.04% |
Max Financial Services Ltd. | 4.02% |
Glenmark Pharmaceuticals Ltd. | 3.78% |
Sai Life Sciences Ltd. | 3.30% |
JK Cement Ltd. | 3.19% |
Name | Akhil Kalluri | Amit Ganatra |
Start Date | 08 Jul 2024 | 03 Oct 2025 |
Name
Start Date
Description | An open-end growth scheme with an objective to provide medium to long term capital appreciation as a primary objective and income as a secondary objective. | The scheme seeks to generate capital appreciation by investing predominantly in Midcap companies |
Launch Date | 30 Oct 1993 | 15 Feb 2007 |
Description
Launch Date